Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duvelisib vs Ofatumumab in Relapsed/Refractory CLL/SLL (DUO)
NCT02004522Phase 3Completed
- Sponsor
- Secura Bio
- Start
- Nov 2013
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of duvelisib in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by Secura Bio. Started Nov 2013; status: completed.
02
Drugs
duvelisib
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT02004522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02004522.